Skip to main content

WHO Guideline on Mass Drug Administration of Azithromycin to Children Under Five Years of Age to Promote Child Survival

Submitted by [email protected] on September 2, 2020 - 09:01 AM

The purpose of the guideline was to provide an evidence-informed recommendation on whether mass drug administration of azithromycin, as a public health intervention for the reduction of under-five mortality, should (a) be rolled out universally in low-and middle-income countries, (b) be applied only in some situational contexts in low- and middle-income countries or (c) not be used at all.

Content Source:

World Health Organization

Content Author:

World Health Organization

Tags: